產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購(gòu) |
---|---|---|---|---|---|---|---|
135091-100MG |
|
117408-99-8 |
2-[(4R)-4,5-二氫-4-苯基-2-惡唑基]吡啶 2-[(4R)-4,5-Dihydro-4-phenyl-2-oxazolyl]pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C14H12N2O | |
134864-100MG |
|
185346-09-2 |
(3aS,3'aS,8aR,8'aR)-2,2'-(2,6-吡啶二基)雙[3a,8a-二氫-8H-茚并[1,2-d]惡唑] (3aS,3'aS,8aR,8'aR)-2,2'-(2,6-Pyridinediyl)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C25H19N3O2 | |
134865-100MG |
|
357209-32-6 |
(3aR,3'aR,8aS,8'aS)-2,2'-(2,6-吡啶二基)雙[3a,8a-二氫-8H-茚并[1,2-d]惡唑] (3aR,3'aR,8aS,8'aS)-2,2'-(2,6-Pyridinediyl)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C25H19N3O2 | |
110362-1G |
|
118949-61-4 |
2,6-雙[(4S)-4-異丙基-2-惡唑啉基]吡啶 2,6-Bis[(4S)-isopropyl-2-oxazolin-2-yl]pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C17H23N3O2 | |
110361-1G |
|
131864-67-0 |
2,6-雙[(4R)-4-異丙基-2-惡唑啉基]吡啶 2,6-Bis[(4R)-isopropyl-2-oxazolin-2-yl]pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C17H23N3O2 | |
100822-1G |
|
118949-63-6 |
2,6-雙[(4S)-4-叔丁基-2-惡唑啉基]吡啶 2,6-Bis[(4S)-4-tert-butyloxazolin-2-yl]pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C19H27N3O2 | |
100821-1G |
|
185346-17-2 |
2,6-雙[(4R)-4-叔丁基-2-噁唑啉基]吡啶 2,6-Bis[(4R)-4-tert-butyloxazolin-2-yl]pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C19H27N3O2 | |
110812-1G |
|
151670-69-8 |
2,6-雙[(4S)-4-芐基-2-惡唑啉基]吡啶 2,6-Bis[(4S)-benzyl-2-oxazolin-2-yl]pyridine 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
1G | 需詢價(jià) | C25H23N3O2 | |
110811-1G |
|
365215-38-9 |
2,6-雙[(4R)-4-芐基-2-惡唑啉基]吡啶 2,6-Bis[(4R)-benzyl-2-oxazolin-2-yl]pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C25H23N3O2 | |
100802-1G |
|
174500-20-0 |
2,6-雙[(4S)-4-苯基-2-惡唑啉基]吡啶 2,6-Bis[(4S)-phenyl-2-oxazolin-2-yl]pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C23H19N3O2 | |
100801-1G |
|
128249-70-7 |
2,6-雙[(4R)-4-苯基-2-惡唑啉基]吡啶 2,6-Bis[(4R)-phenyl-2-oxazolin-2-yl]pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C23H19N3O2 | |
200364-100MG |
|
409312-96-5 |
(4S,4'S)-2,2'-(4,6-二苯并呋喃二基)雙[4,5-二氫-4-異丙基惡唑] (4S,4'S)-2,2'-(4,6-Dibenzofurandiyl)bis[4,5-dihydro-4-isopropyloxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C24H26N2O3 | |
200363-100MG |
|
NA |
(4R,4'R)-2,2'-(4,6-二苯并呋喃二基)雙[4,5-二氫-4-異丙基惡唑] (4R,4'R)-2,2'-(4,6-Dibenzofurandiyl)bis[4,5-dihydro-4-isopropyloxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C24H26N2O3 | |
200362-100MG |
|
246040-77-7 |
(4S,4'S)-2,2'-(4,6-二苯并呋喃二基)雙[4,5-二氫-4-苯基惡唑] (4S,4'S)-2,2'-(4,6-Dibenzofurandiyl)bis[4,5-dihydro-4-phenyloxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C30H22N2O3 | |
200361-100MG |
|
195433-00-2 |
(4R,4'R)-2,2'-(4,6-二苯并呋喃二基)雙[4,5-二氫-4-苯基惡唑] (4R,4'R)-2,2'-(4,6-Dibenzofurandiyl)bis[4,5-dihydro-4-phenyloxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C30H22N2O3 | |
200360-100MG |
|
NA |
(1Z,3Z)-1,3-雙(((S)-4-異丙基-4,5-二氫惡唑-2-基)亞甲基)-1,3-二氫異苯并呋喃 (1Z,3Z)-1,3-Bis[[(S)-4-isopropyl-4,5-dihydrooxazol-2-yl]methylene]-1,3-dihydroisobenzofuran 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C22H26N2O3 | |
200359-100MG |
|
NA |
(1Z,3Z)-1,3-雙(((R)-4-異丙基-4,5-二氫惡唑-2-基)亞甲基)-1,3-二氫異苯并呋喃 (1Z,3Z)-1,3-Bis[[(R)-4-isopropyl-4,5-dihydrooxazol-2-yl]methylene]-1,3-dihydroisobenzofuran 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C22H26N2O3 | |
200358-100MG |
|
NA |
(1Z,3Z)-1,3-雙(((S)-4-苯基-4,5-二氫惡唑-2-基)亞甲基)-1,3-二氫異苯并呋喃 (1Z,3Z)-1,3-Bis[[(S)-4-phenyl-4,5-dihydrooxazol-2-yl]methylene]-1,3-dihydroisobenzofuran 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C28H22N2O3 | |
200357-100MG |
|
NA |
(1Z,3Z)-1,3-雙(((R)-4-苯基-4,5-二氫惡唑-2-基)亞甲基)-1,3-二氫異苯并呋喃 (1Z,3Z)-1,3-Bis[[(R)-4-phenyl-4,5-dihydrooxazol-2-yl]methylene]-1,3-dihydroisobenzofuran 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C28H22N2O3 | |
200356-100MG |
|
1361563-42-9 |
(1Z,3Z)-1,3-雙[[(4S)-4,5-二氫-4-異丙基-2-惡唑基]亞甲基]-2,3-二氫-5,6-二甲基-1H-異吲哚 (1Z,3Z)-1,3-Bis[[(4S)-4,5-dihydro-4-isopropyl-2-oxazolyl]methylene]-2,3-dihydro-5,6-dimethyl-1H-isoindole 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C24H31N3O2 | |